ASPIC

Churchill College, Cambridge, United Kingdom

28 June-01 July, 2015

See more informations here: http://www.eacr.org/cancergenomics2015/index.php

Authors and Affiliations:

Tryfonidis K¹, Senkus E², Cardoso MJ³, Cardoso F³.

Autores e Afiliações:

Tryfonidis K¹, Senkus E², Cardoso MJ³, Cardoso F³.

Authors and Affiliations:

Carla Oliveira*, Hugo Pinheiro*, Joana Figueiredo, Raquel Seruca, Fátima Carneiro

Ipatimup-Institute of Molecular Pathology and Immunology & Instituto Instituto de Investigação e Inovação em Saúde,

(C Oliveira PhD, H Pinheiro PhD, J Figueiredo PhD, R Seruca MD, Prof F Carneiro MD), and

Department of Pathology and Oncology, Faculty of Medicine (C Oliveira, R Seruca, F Carneiro),

University of Porto, Porto, Portugal; and Centro Hospitalar S João, Porto, Portugal (F Carneiro)

Autores e Afiliações:

Carla Oliveira*, Hugo Pinheiro*, Joana Figueiredo, Raquel Seruca, Fátima Carneiro

Ipatimup-Institute of Molecular Pathology and Immunology & Instituto Instituto de Investigação e Inovação em Saúde,

(C Oliveira PhD, H Pinheiro PhD, J Figueiredo PhD, R Seruca MD, Prof F Carneiro MD), and

Department of Pathology and Oncology, Faculty of Medicine (C Oliveira, R Seruca, F Carneiro),

University of Porto, Porto, Portugal; and Centro Hospitalar S João, Porto, Portugal (F Carneiro)

Centro Cultural de Belém, Lisboa, Portugal

14-16 May, 2015

See more informations here: http://www.congresso-lusobrasileiro-oncologia.com/

Centro Cultural de Belém, Lisboa, Portugal

14-16 May, 2015

See more informations here: http://www.congresso-lusobrasileiro-oncologia.com/

Investigadoras do grupo de Genética do Cancro do Ipatimup (Joana Paredes e Ana Sofia Ribeiro) focam o seu estudo na Caderina-P, uma molécula de adesão celular que promove o crescimento tumoral e a invasão de células neoplásicas, sendo um marcador de mau prognóstico no cancro da mama.

Authors and Affiliations:

Ana Sofia Ribeiro and Joana Paredes ^1,2*
¹ Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
² Department of Pathology and Oncology, Faculty of Medicine of the University of Porto, Porto, Portugal

Abstract:

Authors and Affiliations: 

Olga Martinho^1,2,3, Luis E. Zucca³,Rui M. Reis^1,2,3*

¹Life and Health Sciences Research Institute (ICVS), Health Sciences School, University of Minho, Braga, Portugal;

²ICVS/3B’s - PT Government Associate Laboratory, Braga/Guimarães, Portugal;

³Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.

Abstract: